Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment, and that business generates billions of dollars in annual revenue. The biotech has treatment candidate in another indication ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain, sickle cell disease, beta thalassemia, and type 1 diabetes, with approved products in each area. Suzetrigine ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. About one in five Americans suffer from high impact chronic pain – enough pain to interfere ...

Jefferies has upgraded Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), citing the company’s robust cystic fibrosis base business and the additional upside from the new LNP/ mRNA therapy (around $1 billion ...

This program targets the root causes of back pain rather than merely alleviating the symptoms, offering you a chance to reclaim your life without prescription medications or invasive surgeries.

Please provide your email address to receive an email when new articles are posted on . STOMP program interventions reduced pain severity both immediately and after 3 months. Adjustments to the ...

Researchers found that a 12-week therapeutic virtual yoga program for chronic low back pain can be a feasible, safe and effective treatment option. Cleveland Clinic researchers found that a 12-week ...